Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives

by E. Krasniqi, G. Barchiesi, L. Pizzuti, M. Mazzotta, A. Venuti, M. Maugeri-Saccà, G. Sanguineti, G. Massimiani, D. Sergi, S. Carpano, P. Marchetti, S. Tomao, T. Gamucci, R. De Maria, F. Tomao, C. Natoli, N. Tinari, G. Ciliberto, M. Barba, P. Vici
Published 2019-10-01

Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”

by D. Brocco, P. Lanuti, P. Simeone, G. Bologna, D. Pieragostino, M. C. Cufaro, V. Graziano, M. Peri, P. Di Marino, M. De Tursi, A. Grassadonia, I. G. Rapposelli, L. Pierdomenico, E. Ercolino, F. Ciccocioppo, P. Del Boccio, M. Marchisio, C. Natoli, S. Miscia, N. Tinari
Published 2020-01-01

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

by D. Brocco, P. Lanuti, P. Simeone, G. Bologna, D. Pieragostino, M. C. Cufaro, V. Graziano, M. Peri, P. Di Marino, M. De Tursi, A. Grassadonia, I. G. Rapposelli, L. Pierdomenico, E. Ercolino, F. Ciccocioppo, P. Del Boccio, M. Marchisio, C. Natoli, S. Miscia, N. Tinari
Published 2019-01-01

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

by E. Krasniqi, A. Sacconi, D. Marinelli, L. Pizzuti, M. Mazzotta, D. Sergi, E. Capomolla, S. Donzelli, M. Carosi, A. Bagnato, T. Gamucci, S. Tomao, C. Natoli, P. Marchetti, A. Grassadonia, N. Tinari, M. De Tursi, E. Vizza, G. Ciliberto, L. Landi, F. Cappuzzo, M. Barba, G. Blandino, P. Vici
Published 2021-07-01